Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsAntibody–drug nanoparticles were engineered by synthesizing pure anti-cancer drug nanorods in the core of nanoparticles with a therapeutic monoclonal antibody, Trastuzumab on the surface of NRs for specific targeting and synergistic treatments of human epidermal growth factor receptor 2 positive breast cancer cells.
[Scientific Reports]
6445218 {6445218:CLBLYVHA} apa 50 1 160783 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-2454a0b006608590d715687cc330cc9a%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22CLBLYVHA%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Abedin%20et%20al.%22%2C%22parsedDate%22%3A%222021-04-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EAbedin%2C%20M.%20R.%2C%20Powers%2C%20K.%2C%20Aiardo%2C%20R.%2C%20Barua%2C%20D.%2C%20%26amp%3B%20Barua%2C%20S.%20%282021%29.%20Antibody%26%23x2013%3Bdrug%20nanoparticle%20induces%20synergistic%20treatment%20efficacies%20in%20HER2%20positive%20breast%20cancer%20cells.%20%3Ci%3EScientific%20Reports%3C%5C%2Fi%3E%2C%20%3Ci%3E11%3C%5C%2Fi%3E%281%29%2C%207347.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-021-86762-6%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41598-021-86762-6%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DCLBLYVHA%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Antibody%5Cu2013drug%20nanoparticle%20induces%20synergistic%20treatment%20efficacies%20in%20HER2%20positive%20breast%20cancer%20cells%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Muhammad%20Raisul%22%2C%22lastName%22%3A%22Abedin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaitlyne%22%2C%22lastName%22%3A%22Powers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Aiardo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dibbya%22%2C%22lastName%22%3A%22Barua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sutapa%22%2C%22lastName%22%3A%22Barua%22%7D%5D%2C%22abstractNote%22%3A%22Chemotherapeutic%20drugs%20suffer%20from%20non-specific%20binding%2C%20undesired%20toxicity%2C%20and%20poor%20blood%20circulation%20which%20contribute%20to%20poor%20therapeutic%20efficacy.%20In%20this%20study%2C%20antibody%5Cu2013drug%20nanoparticles%20%28ADNs%29%20are%20engineered%20by%20synthesizing%20pure%20anti-cancer%20drug%20nanorods%20%28NRs%29%20in%20the%20core%20of%20nanoparticles%20with%20a%20therapeutic%20monoclonal%20antibody%2C%20Trastuzumab%20on%20the%20surface%20of%20%20NRs%20for%20specific%20targeting%20and%20synergistic%20treatments%20of%20human%20epidermal%20growth%20factor%20receptor%202%20%28HER2%29%20positive%20breast%20cancer%20cells.%20ADNs%20were%20designed%20by%20first%20synthesizing%5Cu2009~%5Cu200995%5Cu00a0nm%20diameter%5Cu2009%5Cu00d7%5Cu2009~%5Cu2009500%5Cu00a0nm%20long%20paclitaxel%20%28PTX%29%20NRs%20using%20the%20nanoprecipitation%20method.%20The%20surface%20of%20PTXNRs%20was%20functionalized%20at%202%5Cu2032%20OH%20nucleophilic%20site%20using%20carbonyldiimidazole%20and%20conjugated%20to%20TTZ%20through%20the%20lysine%20residue%20interaction%20forming%20PTXNR-TTZ%20conjugates%20%28ADNs%29.%20The%20size%2C%20shape%2C%20and%20surface%20charge%20of%20ADNs%20were%20characterized%20using%20scanning%20electron%20microscopy%20%28SEM%29%2C%20SEM%2C%20and%20zeta%20potential%2C%20respectively.%20Using%20fluorophore%20labeling%20and%20response%20surface%20analysis%2C%20the%20percentage%20conjugation%20efficiency%20was%20found%5Cu2009%3E%5Cu200995%25%20with%20a%20PTX%20to%20TTZ%20mass%20ratio%20of%204%20%28molar%20ratio%20%5Cu2248%20682%29.%20In%20vitro%20therapeutic%20efficiency%20of%20PTXNR-TTZ%20was%20evaluated%20in%20two%20HER2%20positive%20breast%20cancer%20cell%20lines%3A%20BT-474%20and%20SK-BR-3%2C%20and%20a%20HER2%20negative%20MDA-MB-231%20breast%20cancer%20cell%20using%20MTT%20assay.%20PTXNR-TTZ%20inhibited%5Cu2009%3E%5Cu200980%25%20of%20BT-474%20and%20SK-BR-3%20cells%20at%20a%20higher%20efficiency%20than%20individual%20PTX%20and%20TTZ%20treatments%20alone%20after%2072%5Cu00a0h.%20A%20combination%20index%20analysis%20indicated%20a%20synergistic%20combination%20of%20PTXNR-TTZ%20compared%20with%20the%20doses%20of%20single-drug%20treatment.%20Relatively%20lower%20cytotoxicity%20was%20observed%20in%20MCF-10A%20human%20breast%20epithelial%20cell%20control.%20The%20molecular%20mechanisms%20of%20PTXNR-TTZ%20were%20investigated%20using%20cell%20cycle%20and%20Western%20blot%20analyses.%20The%20cell%20cycle%20analysis%20showed%20PTXNR-TTZ%20arrested%5Cu2009%3E%5Cu200980%25%20of%20BT-474%20breast%20cancer%20cells%20in%20the%20G2%5C%2FM%20phase%2C%20while%5Cu2009%3E%5Cu200970%25%20of%20untreated%20cells%20were%20found%20in%20the%20G0%5C%2FG1%20phase%20indicating%20that%20G2%5C%2FM%20arrest%20induced%20apoptosis.%20A%20similar%20percentage%20of%20G2%5C%2FM%20arrested%20cells%20was%20found%20to%20induce%20caspase-dependent%20apoptosis%20in%20PTXNR-TTZ%20treated%20BT-474%20cells%20as%20revealed%20using%20Western%20blot%20analysis.%20PTXNR-TTZ%20treated%20BT-474%20cells%20showed%5Cu2009~%5Cu20091.3%2C%201.4%2C%20and%201.6-fold%20higher%20expressions%20of%20cleaved%20caspase-9%2C%20cytochrome%20C%2C%20and%20cleaved%20caspase-3%2C%20respectively%20than%20untreated%20cells%2C%20indicating%20up-regulation%20of%20caspase-dependent%20activation%20of%20apoptotic%20pathways.%20The%20PTXNR-TTZ%20ADN%20represents%20a%20novel%20nanoparticle%20design%20that%20holds%20promise%20for%20targeted%20and%20efficient%20anti-cancer%20therapy%20by%20selective%20targeting%20and%20cancer%20cell%20death%20via%20apoptosis%20and%20mitotic%20cell%20cycle%20arrest.%22%2C%22date%22%3A%222021-04-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41598-021-86762-6%22%2C%22ISSN%22%3A%222045-2322%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41598-021-86762-6%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-04-01T22%3A07%3A20Z%22%7D%7D%5D%7D
Abedin, M. R., Powers, K., Aiardo, R., Barua, D., & Barua, S. (2021). Antibody–drug nanoparticle induces synergistic treatment efficacies in HER2 positive breast cancer cells. Scientific Reports, 11(1), 7347. https://doi.org/10.1038/s41598-021-86762-6 Cite
